According to a research report titled ‘Global DNA Sequencing Market Size study, by Product & Services (Consumables, Instruments, Services), by Technology (Sanger Sequencing, Next-Generation Sequencing, Third Generation DNA Sequencing), by Workflow (Pre-sequencing, Sequencing, Data Analysis), by Application (Oncology, Reproductive Health, Clinical Investigation, Agrigenomics & Forensics, HLA Typing/Immune System Monitoring, Others), by End-Use (Academic Research, Clinical Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other Users) and Regional Forecasts 2020-2027’, available with Market Study Report, global DNA sequencing market was valued at USD 4.7 billion in 2019 and is anticipated to record a y-o-y growth rate of 11.3% CAGR to accumulate USD 11.1 billion by the year 2027.
 

As per report findings, DNA sequencing has become inevitable for basic biological research and is being applied in a wide range of medical fields such as virology, biological systematics, biotechnology, medical diagnosis, and forensic biology, hence stimulating worldwide DNA sequencing industry demand.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3002313/
 

Furthermore, rising prevalence of chronic diseases like cancer, increase in number of DNA tests, and rapid developments in bioinformatics and sequencing technology are few other factors propelling market growth. As per the Centers for Genetics and Society, over 26 million people have provided their DNA test results for commercial ancestry and health databases by the beginning of 2019, a steep increase of around 11 million from 2018. These statistics indicate increasing adoption of the DNA sequencing all over the world.
 

For the unversed, DNA sequencing is a process of determining the nucleic acid sequence. It enables researchers and scientists to sequence genomes and genes which provide crucial information regarding mutations that cause diseases.
 

However, a lack of skilled professionals, and required interpretation of complex data are anticipated to hamper global DNA sequencing market remuneration.
 

Based on products & services terrain, the industry is arrayed into services, consumables, and instruments. By workflow type, worldwide DNA sequencing industry is split into sequencing, pre-sequencing, and data analysis.
 

Moving on to application ambit, HLA typing/immune system monitoring, oncology, agrigenomics & forensics, reproductive health, and clinical investigation among others contribute towards market valuation.
 

Elaborating on end user spectrum, global DNA sequencing market is categorized into clinical research, academic research, pharmaceutical & biotechnology companies, and hospitals among others.
 

On the regional front, North America dominated the market forecast in the recent past, owing to quick adoption of advanced technology, and availability of suppliers in the region. However, Asia Pacific industry share is anticipated to record the highest growth rate during the forecast period due to growing geriatric population, and rise in number of cancer patients, coupled with improved awareness about DNA sequencing in countries like China as well as India.
 

Key players in global DNA sequencing market are Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Pacific Biosciences of California, Inc., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Oxford Nanopore Technologies Ltd., Macrogen, Inc., Illumina, Inc., Qiagen N.V., and F. Hoffmann-La Roche Ltd.